3Chapman JS,Georgopapadakou NH. F1uorometric assay for fleroxacin uptake by bacterial cells.Antimicrob. Agents Chemother,1989;33(1):27.
4Mortimer PGS, Piddock LJV.A comparison of methods used for measuring the accumulation of quinolones by Enterob-acteriaceae, Pseudomonas aeruginosa,and Staphylococcusa aureus.J Antimicrob Chemother,1991;28(2):639.
5Nikaido H,Thanassi DG.Penetration of lipophilic agents with multiple protonation sites into bacterial cells:tetracyclines and fluoroquinones as examples. Antimicrob. Agents Chemother,1993;37(7):1393.
6Li XZ, Livermaore DM, Nikaido H. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa:Resistance to tetracycline,chloramphenical,and norfloxacin.Antimicrob.Agents Chemother,1994;38(8):1732.
7Mc Murry LM,George AM,Levy SB.Active efflux of chloramphenicol in susceptible Escherichia coli strains and in multiple- antibiotic- resistant(Mar)mutant. AntimicrobAgents Chemother,1994;38(3):542.
8Thanassi DG,Suh GSB,Nikaido H.Role of outer membrane barrier in efflux-mediated tetracycline resistance of Escherichia coli.J Bacteriol.1995;177(4):998.
9Mccaffrey C,Bertasso A,Pace J, et al.Quinolone accumulation in Escherichia coli,Pseudomonas aeruginosa,and Staphylococcus. Antimicrob Agents Chemother,1992;36(4):1601.
10Denis A,Moreau NJ.Mechanisms of quinolone resistance in clinic isolates: accumulation of sparfloxacin and fluoroquinolones of various hydrophobicity and analysis of membrane composition.Antimicrob Agents Chemother,1993;32(3):379.
6Bagel S, Hullen V, Wiedemann B, Heisig P. Impact of gyrA and parC mutations on quinolne resistance, doubling time, and supercoiling degree of Esherichia coli. Antimicrobial Agents and Chemotherapy, 1999, 43(4): 868-875.
7Matrat S, Petrella S, Cambau E, Sougakoff W, Jarlier V, Aubry A. Expression and purification of an active form of the Mycobacterium leprae DNA gyrase and its inhibition by quinolones. Antimicrobial Agents and Chemotherapy, 2007, 51 (5): 1643-1648.
8Sorlozano A, Gutierrez J, Jimenez A, Contribution of a new mutation in parE Luna J D, Martinez J L. to quinolone resistance in extended-spectrum-β-Lactamase-producing Escherichia coli isolates. Journal of Clinical Microbiology, 2007, 45 (8): 2740-2742.
9Tran J H, Jacoby G A, Hooper D C. Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrobial Agents and Chemotherapy, 2005, 49(1): 118-125.
10Yue L, Jiang H X, Liao X P, Liu J H, Li S J, Chen X Y, Chen C X, Lu D H, Liu Y H. Prevalence of plasmid-mediated qninolone resistance qnr genes in poultry and swine clinical isolates of Escherichia coli. Veterinary Microbiology, 2008, 132: 414-420.
